How Bendheim was paid
$5.3M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Incentive | Pension | Other | Total |
|---|---|---|---|---|---|---|
| Jack C. BendheimChairman of the Board, President, and Chief Executive Officer | $2,442,600 | $500,000 | $1,677,300 | $168,087 | $496,135 | $5,284,122 |
| Glenn DavidChief Financial Officer | $672,767 | $100,000 | $462,000 | — | $39,180 | $1,273,947 |
| Larry L. MillerChief Operating Officer | $710,850 | $1,162,500 | $488,150 | $13,169 | $54,869 | $2,429,538 |
| Daniel M. BendheimDirector and Executive Vice President, Corporate Strategy | $575,000 | $100,000 | $394,850 | $2,672 | $47,258 | $1,119,780 |
| Judith WeinsteinSenior Vice President, General Counsel and Corporate Secretary | $500,000 | $150,000 | $343,350 | $2,876 | $47,701 | $1,043,927 |
What changed and why
- $5.3M$5,284,122 CEO total compensation increased from $4,753,878 in fiscal 2024.
- $1.7M$1,677,300 CEO MIP compensation represented the largest component of fiscal 2025 pay.
- $500K$500,000 CEO discretionary bonus recognized individual contributions, Phibro Forward, and acquisitions.
- $0$0 equity awards were granted to NEOs during fiscal 2025.
- $55,85495:1 CEO-to-median-employee pay ratio was based on median employee compensation of $55,854.
- $550K$550,000 was the aggregate maximum cost of certain family services and coverage for the CEO’s family.
Other Phibro Animal Health proxy statements
- 2026 proxy statement
Jack C. Bendheim paid $5.2M (-1% on the year), pay ratio 74:1.
Filed Sep 18, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.